act primary disease compared to local palliative therapy only in patients with stage IV breast cancer, whose disease does not progress during initial optimal systemic therapy, will result in prolonged survival.SecondaryTo compare the time to uncontrolled chest wall disease between patients treated with these regimens.To determine whether there is a difference in health-related quality-of-life (HRQ